$INKT
MiNK Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INKT up today? It is at $12.20 (+4.99%). See the catalyst behind the move, real-time alerts the moment INKT spikes, and full due diligence on INKT — key stats, earnings, dilution and insider activity. Free.
Get free $INKT alerts the moment volume spikes
Be first to know when $INKT makes an unusual move. Create a free account to track $INKT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $12.20
- Change today
- +4.99%
- Previous close
- $11.62
- 52-week range
- $8.48 – $16.98
- Market cap
- $62M
- Institutional own.
- 5.33%
- Total held
- 5.3%
- Tradeable float
- 4.8M 95% of shares · after 5% institutions
- Short interest
- 94K ▼ -6% vs prior · as of 2026-07-31
- Short % of float
- 1.9%
- Days to cover
- 9.4d
- Avg daily volume
- 94K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 0.3x
- 15mthin
- 0.3x
- 1hthin
- 0.4x
- 1D
- --
Get free INKT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $INKT up today?
Here is the latest on INKT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INKT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying5 buys, 1 sells last 3 months (23/5 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ryan Barbara Director | Sold (automatic/other) | -2K 0.03% of company | sold 6.4% | 22K | $19K at $12.68 | Jun 4, 26 |
Wiinberg Ulf Director | Acquired (grant/award) | +1K 0.02% of company | added 5.3% | 23K | $14K at $12.38 | Jun 1, 26 |
Behner Peter Director | Acquired (grant/award) | +1K 0.03% of company | added 6.1% | 23K | $16K at $12.38 | Jun 1, 26 |
Corvese Brian Director | Acquired (grant/award) | +1K 0.03% of company | added 2.8% | 53K | $18K at $12.38 | Jun 1, 26 |
Ryan Barbara Director | Acquired (grant/award) | +1K 0.03% of company | added 6.5% | 23K | $18K at $12.38 | Jun 1, 26 |
Holcomb John Bradley Director | Acquired (grant/award) | +1K 0.02% of company | added 46% | 3K | $14K at $12.38 | Jun 1, 26 |
Ryan Barbara Director | Sold (automatic/other) | -1K 0.03% of company | sold 6.0% | 20K | $20K at $15.28 | Mar 10, 26 |
Ryan Barbara Director | Sold (automatic/other) | -200 | sold 0.9% | 22K | $2K at $10.17 | Mar 9, 26 |
Ryan Barbara Director | Sold (automatic/other) | -100 | sold 0.5% | 22K | $1K at $10.83 | Mar 2, 26 |
Ryan Barbara Director | Acquired (grant/award) | +2K 0.03% of company | added 8.0% | 22K | $18K at $10.90 | Mar 2, 26 |
Wiinberg Ulf Director | Acquired (grant/award) | +1K 0.03% of company | added 6.4% | 22K | $14K at $10.90 | Mar 2, 26 |
Behner Peter Director | Acquired (grant/award) | +1K 0.03% of company | added 7.4% | 22K | $16K at $10.90 | Mar 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $INKT. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$INKT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
Stocks similar to INKT
Comparable names in biological products, (no diagnostic substances), closest in size first.
INKT stock FAQ
Why is $INKT up today?
Here is the latest on INKT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INKT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the INKT stock price today?
INKT last traded at $12.20, up 4.99% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live INKT alerts?
The INKT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INKT 0 times in the last 30 days.
What exchange is INKT on?
INKT (MiNK Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $62M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is INKT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INKT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.